Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
367 Verona Avenue , Newark, NJ, 07104, US
Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation requires tighter coordination across formulation, characterization, and preclinical testing.
By: Tim Wright
In this Q&A, Ingenza CEO Nick Challoner, discusses how CRDMOs must evolve to help biotech companies accelerate development, reduce risk, and translate scientific innovation into scalable commercial success.
The partners seek to define and subsequently develop an allogeneic pancreatic beta cell therapy based on patient needs.
By: Patrick Lavery
Why some CDMOs reduce risk while others unintentionally create it.
By: Lorna Patrick
As CGT programs move toward scale, the bigger challenge is no longer capacity alone, but keeping the full supply chain aligned across sites, vendors, and handoffs.
Released By Cryoport Systems
Huang brings 25+ years of leadership experience across the pharmaceutical and CDMO sectors.
By: Charlie Sternberg
Collaboration will apply Cellares' Cell Shuttle and Cell Q platforms to TSC-101 as a potentially scalable and cost-efficient path to commercialization.
By: Kristin Brooks
To offer and distribute Dow's Decarbia low-carbon products across key markets.
Mr. Wang will spearhead the integration of computational science and data-driven decision-making across the R&D operation.
De Ganck will help ensure Ardena’s scientific expertise is effectively aligned across services and sites.
The partnership includes licensing, co-development, and co-commercialization opportunities across a diverse portfolio of antibody-drug conjugates.
Phase II starts are increasing the fastest of all clinical phases, trials are running leaner, and the safety data challenge is growing.
By: Patrick Hughes
A growing list of pharmaceutical companies have been adopting the platform in the last year-plus.
New avian cell line aims to speed recombinant MVA development and improve manufacturing reliability.
When key decisions are delayed, pressure builds where execution has the least room to adjust.
Released By Thermo Fisher Scientific Pharma Services
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
